<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0108222380
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1993
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        COMPOUND SODIUM LACTATE INF.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE,POTASSIUM CHLORIDE, CALCIUM CHLORIDE,SODIUM LACTATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        6,0.40,0.27,3.20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        6.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharmaceutical Solution Industries (PSI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 444]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharmaceutical Solution Industries (PSI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Compound Sodium Lactate Infusion is a solution of the following substances in water: &bull; sodium<br />chloride &bull; potassium chloride<br />&bull; Calcium chloride dihydrate &bull; sodium lactate.<br />Compound Sodium Lactate Infusion is used:<br />&bull; To treat a loss of body water and chemicals (e.g. by heavy sweating, kidney disorders)<br />&bull; To treat you, if the volume of blood in your blood vessels is low (hypovolaemia) or if you have<br />low blood pressure (hypotension) &bull; in metabolic acidosis (when the blood becomes too acidic).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You must NOT receive Compound Sodium Lactate Infusion if you are suffering from any of<br />the following conditions<br />&bull; If you&rsquo;re a newborn (less than 28 days old) receiving ceftriaxone (an antibiotic) &bull; If you&rsquo;re<br />allergic to sodium lactate or any of the other ingredients in Compound Sodium Lactate<br />(listed in section 6)<br />&bull; When there is too much fluid in the spaces around the cells of the body (extracellular<br />hyperhydration)<br />&bull; When there is a larger volume of blood in the blood vessels than there should be<br />(hypervolaemia)<br />&bull; Severe kidney failure (when your kidneys do not work well and you require dialysis)<br />&bull; Uncompensated heart failure. This is heart failure that is not adequately treated and<br />causes symptoms such as: &ndash; shortness of breath &ndash; swelling of the ankles<br />&bull; Higher levels of potassium in the blood than normal (hyperkalaemia)<br />&bull; Higher levels of calcium in the blood than normal (hypercalcaemia)<br />&bull; A disorder in which the blood becomes too alkaline (metabolic alkalosis)<br />&bull; Liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis) &bull; your<br />blood is too acidic which is life-threatening (severe metabolic acidosis)<br />&bull; A particular type of metabolic acidosis (lactic acidosis)<br />&bull; Severe liver disease (when the liver does not function properly and requires very intensive treatment)<br />&bull; Poor lactate metabolism (this occurs in severe liver disease, as lactate is removed by the liver)<br />&bull; If you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as<br />digitalis or digoxin (see also &ldquo;Taking other medicines&rdquo;)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><br />You will be given Compound Sodium Lactate Infusion by a doctor or nurse. Your doctor will<br />decide on how much you need and when it is to be given. This will depend on your age,<br />weight, condition and the reason for treatment.<br />The amount you are given may also be affected by other treatments you are receiving. You<br />should NOT be given Compound Sodium Lactate Infusion if there are particles floating in<br />the solution or if the pack is damaged in any way. Compound Sodium Lactate Infusion will<br />usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein<br />in your arm is used to give you the infusion. However, your doctor may use another method<br />to give you the medicine. Before and during the infusion, your doctor will monitor:<br />&bull; The amount of fluid in your body<br />&bull; The acidity of your blood and urine<br />&bull; The amount of electrolytes in your body (particularly sodium, in patients with high level of<br />the vasopressin, or if you are taking other medicines which increase the effect of<br />vasopressin). Any unused solution should be thrown away. You should NOT be given an<br />infusion of Compound Sodium Lactate Infusion from a bag that has been partly used.<br />If you receive more Compound Sodium Lactate Infusion than you should<br />If you are given too much Compound Sodium Lactate Infusion (over-infusion) or it is given<br />too fast, this may lead to the following symptoms:<br />&bull; Water and/or sodium (salt) overload with build-up of liquid in the tissues (oedema) causing swelling</p><p>&bull; Hyperkalaemia (higher levels of potassium in the blood than normal) especially in patients<br />with kidney failure, causing symptoms such as:<br />&ndash; Pins and needles in the arms and legs (paraesthesia)<br />&ndash; Muscle weakness<br />&ndash; An inability to move (paralysis)<br />&ndash; An irregular heartbeat (cardiac arrhythmias)<br />&ndash; Heart block (a very slow heartbeat)<br />&ndash; Cardiac arrest (the heart stops beating; a life-threatening situation)<br />&ndash; Confusion<br />&ndash; hypercalcaemia (higher levels of calcium in the blood than normal) causing symptoms such as:<br />- A decreased appetite (anorexia)<br />- Feeling sick (nausea)<br />- Vomiting<br />- Constipation<br />- Abdominal pain<br />- Mental disturbances such as irritability or depression<br />- Drinking lots of water (polydipsia) - producing more urine than normal (polyuria) - Kidney<br />disease due to build-up of calcium in the kidneys (nephrocalcinosis)<br />- Kidney stones<br />- Coma (unconsciousness)<br />- Chalky taste<br />- Redness (hot flushes)<br />- Dilatation of the blood vessels in the skin (peripheral vasodilatation).<br />&bull; Hypokalaemia (lower levels of potassium in the blood than normal) and metabolic alkalosis<br />(when the blood becomes too basic), especially in patients with kidney failure, causing<br />symptoms such as:<br />&ndash; Mood changes<br />&ndash; Tiredness<br />&ndash; Shortness of breath<br />&ndash; Stiffness of the muscles<br />&ndash; Twitching of the muscles<br />&ndash; Contraction of muscles.<br />If you develop any of these symptoms you must inform your doctor immediately. Your<br />infusion will be stopped and you will be given treatment depending on the symptoms. If a<br />medicine has been added to your Compound Sodium Lactate Infusion before over-infusion<br />occurs, that medicine may also cause symptoms. You should read the Package Leaflet of<br />the added medicine for a list of possible symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><br />Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you have any of the following symptoms you should tell your doctor or nurse immediately.<br />These may be signs of a very severe or even fatal hypersensitivity (allergic) reaction called<br />anaphylactic shock:<br />&bull; Hives (urticaria) which may be localised to a part of the body or widespread<br />&bull; Skin rash<br />&bull; Redness of the skin (erythema)<br />&bull; Itching (pruritus)<br />&bull; Skin swelling (angioedema)<br />&bull; Coughing<br />&bull; Narrowing of the airways causing difficulty breathing (bronchospasm)<br />&bull; A fast heartbeat (tachycardia)<br />&bull; A slow heartbeat (bradycardia)<br />&bull; Decreased blood pressure<br />&bull; Chest discomfort or pain<br />&bull; Anxiety<br />&bull; Tightness of the chest (making it difficult to breathe)<br />&bull; Shortness of breath (dyspnea)<br />&bull; Flushing<br />&bull; Throat irritation<br />&bull; Pins and needles (paraesthesia)<br />&bull; Reduced sense in the mouth (hypoesthesia oral)<br />&bull; Altered taste (dysgeusia)<br />&bull; Fever (pyrexia)<br />&bull; Nausea<br />&bull; Headache<br />Higher levels of potassium in the blood than normal (hyperkalaemia)<br />Low levels of sodium in the blood that may be acquired during hospitalization (nosocomial<br />hyponatraemia) and related neurological disorder (acute hyponatraemic encephalopathy).<br />Hyponatraemia can lead to irreversible brain injury and death due to cerebral<br />oedema/swelling see also section 2 &ldquo;Warnings and precautions&rdquo;).<br />Reactions due to the administration technique manifested by one or more of the following<br />symptoms:<br />&bull; Local pain or reaction redness or swelling at the site of infusion<br />&bull; Irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause<br />redness, pain or burning and swelling along the path of the vein into which the solution is infused.<br />&bull; Rash or itching (pruritus) of the infusion site. Other side effects noted with similar products<br />(other sodium-lactate containing solutions) include:<br />&bull; Other manifestations of hypersensitivity/infusion reactions: a blocked nose (nasal<br />congestion), sneezing, swelling in the throat making it difficult to breathe (laryngeal oedema<br />also called Quincke&rsquo;s oedema), skin swelling (angioedema)<br />&bull; Changes in the concentrations of the chemicals in the blood (electrolyte disturbances)<br />&bull; A larger volume of blood in the blood vessels than there should be (hypervolemia) &bull; panic attack<br />&bull; Other reactions due to the administration technique: infection at the site of infusion,<br />escape of the infusion solution into the tissues around the vein (extravasation). This can<br />damage the tissues and cause scarring, numbness at the site of infusion.<br />If a medicine has been added to the solution for infusion, the added medicine may also<br />cause side effects. These side effects will depend on the medicine that has been added.<br />You should read the Package Leaflet of the added medicine for a list of possible symptoms.<br />Reporting of side effects<br />If you get any side effect, talk to your doctor or nurse. This includes any possible side effect<br />not listed in this leaflet. By reporting side effects, you can help provide more information on<br />the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children. Do not store above 30&deg;C.<br />Compound Sodium Lactate Infusion should NOT be given to you after the expiry date which<br />is stated on the bag after EXP</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><br />The active substances are:<br />&bull; Sodium chloride<br />&bull; Potassium chloride<br />&bull; Calcium chloride dihydrate<br />&bull; Sodium lactate<br />The only other ingredient is water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Compound Sodium Lactate Infusion is a clear solution, free from visible particles. It is.
supplied in plastic bottle 500 ml and 1000 ml.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder and Manufacturer<br />Pharmaceutical Solutions Industry Ltd.<br />Industrial Estate, Phase-2,<br />Road No. 208, Str. - 203<br />P O Box 17476<br />Jeddah 21484<br />Western Province<br />Saudi Arabia<br />Phone: +966-12-6361383<br />FAX: +966-12-6379460<br />Website: http://www.psiltd.com<br />&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&bull; Saudi Arabia:<br />National Pharmacovigilance and drug safety Center (NPC)<br />Fax: +966-11-2057662<br />Toll free: 8002490000<br />Tel: +966-11-2038222 Ext. 2317-2334-2340 &ndash;2353 &ndash;2354- 2356<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc</p><p>Other GCC States:<br />Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><br />مركب الصوديوم لاكتيت هو محلول يتضمن المواد التالية في الماء:<br />&bull; كلوريد الصوديوم<br />&bull; كلوريد البوتاسيوم<br />&bull; ثنائي كلوريد الكالسيوم<br />&bull; لاكتيت الصوديوم<br />&bull;مركب الصوديوم لاكتيت يستخدم لعلاج فقدان مياه الجسم والمواد الكيميائية (مثل التعرق الشديد ، واضطرابات الكلى)<br />&bull; لعلاجك إذا كان حجم الدم في الأوعية الدموية منخفضًا (نقص حجم الدم) أو إذا كان لدیك انخفاض في<br />ضغط الدم (انخفاض ضغط الدم)<br />&bull; في الحماض الاستقلابي (عندما يصبح الدم حمضييا جدًا).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يجب ألا تتلقى مركب الصوديوم لاكتيت إذا كنت تعاني من أي من الحالات التالية:<br />&bull; إذا كنت مولودًا جديدًا (أقل من ۲۸ يومًا) تتلقى سيفترياكسون (مضاد حيوي)<br />&bull; إذا كنت تعاني من حساسية من لاكتات الصوديوم أو أي من المكونات الأخرى في مركب الصوديوم لاكتات<br />( (مدرج في القسم ٦<br />&bull; عندما يكون هناك الكثير من السوائل في المساحات المحيطة بخلايا الجسم (فرط الجفاف خارج الخلية)<br />&bull; عندما يزيد حجم الدم في الأوعية الدموية اكثر مما يجب<br />&bull; الفشل الكلوي الحاد (عندما لا تعمل كليتك جيدًا وتحتاج إلى غسيل الكلى)<br />&bull; قصور القلب غير المكافئ (فشل القلب الذي لا يتم علاجه&nbsp;بشكل كاف ويسبب أعراضًا مثل: - ضيق التنفس - تورم الكاحلين)<br />&bull; ارتفاع مستويات البوتاسيوم في الدم عن المعدل الطبيعي (فرط بوتاسيوم الدم)<br />&bull; ارتفاع مستويات الكالسيوم في الدم عن المعدل الطبيعي (فرط كالسيوم الدم)<br />&bull; اضطراب يصبح فيه&nbsp;الدم قلوييا جدًا (قلاء استقلابي)<br />&bull; مرض الكبد الذي يتسبب في تراكم السوائل داخل البطن (تليف الكبد الحاد).<br />&bull; دمك شديد الحموضة وهو ما يهدد الحياة (الحماض الأيضي الحاد)<br />&bull; نوع معين من الحماض الايضي (الحماض اللبني)<br />&bull; مرض الكبد الحاد (عندما لا يعمل الكبد بشكل صحيح ويتطلب علاجًا مكثفًا للغاية)<br />&bull; ضعف استقلاب اللاكتات (يحدث هذا في مرض الكبد الحاد ، حيث تتم إزالة اللاكتات بواسطة الكبد)<br />&bull; إذا كنت تتناول الجليكوسيدات المستخدمة لعلاج قصور القلب ، مثل الديجيتال أو الديجوكسين (انظر أيضًا<br />&quot;تناول أدویة أخرى&quot;).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سوف يتم إعطاؤك مركب الصوديوم لاكتيت من قبل طبيب أو ممرضة.<br />سيقرر طبيبك مقدار ما تحتاجه&nbsp;ومتى يتم إعطاؤه. هذا يعتمد على عمرك والوزن والحالة وسبب العلاج.<br />قد تتأثر الكمية الذي قدمت لك من محلول مركب الصوديوم لاكتيت أيضًا بالعلاجات الأخرى التي تتلقاها.<br />يجب عدم إعطاؤك مركب الصوديوم لاكتيت اذا كان هناك جسيمات تطفو بالمحلول او اذا كانت العبوة تالفة.<br />عادةً ما يتم إعطاؤك مركب الصوديوم لاكتيت من خلال أنبوب بلاستيكي متصل بأبرة في الوريد.<br />عادة ما يتم استخدام الوريد في ذراعك لإعطائك الحقن في الوريد. ومع ذلك ، قد يستخدم الطبيب طريقة<br />أخرى لإعطائك الدواء. قبل وأثناء اعطاء المحلول ، سيقوم طبيبك بمراقبة:<br />- كمية السائل في جسمك<br />- حموضة دمك والبول<br />- كمیة الإلكتروليت في جسمك (خاصة الصوديوم ، في المرضى الذیين يعانون من ارتفاع مستوى فاسوبريسين<br />، أو إذا كنت تتناول أدوية أخرى تزيد من تأثير فاسوبريسين). يجب التخلص من أي محلول غير مستخدم.<br />يجب عدم إعطاؤك مركب الصوديوم لاكتيت&quot; من عبوة تم استخدامها جزئيا.<br />إذا تلقيت كمية أكبر من هذا الدواء أكثر مما ينبغي:<br />إذا تم إعطاؤك الكثير من مركب الصوديوم لاكتيت (الإفراط في التسريب) أو تم إعطاؤها بسرعة كبيرة ، فقد<br />يؤدي ذلك إلى الأعراض التالية:<br />- الماء و / أو الصوديوم (الملح) الزائد مع تراكم السائل في الأنسجة (وذمة) مما تسبب تورم<br />- فرط بوتاسيوم الدم (مستويات البوتاسيوم في الدم أعلى من المعتاد) وخاصة في المرضى الذين يعانون من<br />الفشل الكلوي ، مسببة أعراض مثل:<br />- دبابيس وإبر في الذراعين والساقين (مذل)<br />- ضعف العضلات<br />- عدم القدرة على الحركة (الشلل)<br />- عدم انتظام ضربات القلب (عدم انتظام ضربات القلب)<br />- كتلة القلب (نبضات بطيئة جدا)<br />- السكتة القلبية (توقف القلب عن الخفقان ؛ وضع يهدد الحياة)<br />- الارتباك<br />- فرط كالسيوم الدم (مستويات الكالسيوم في الدم أعلى من المعتاد) مسببة أعراض مثل<br />- انخفاض الشهية (فقدان الشهية)<br />- الشعور بالمرض (غثيان)<br />- القيء<br />- الإمساك<br />- وجع بطن<br />- الاضطرابات العقلية مثل التهيج أو الاكتئاب<br />- شرب الكثير من الماء<br />- إنتاج كمية أكبر من البول عن المعتاد<br />(- أمراض الكلى بسبب تراكم الكالسيوم في الكلى (الكلوية<br />- حصى الكلى<br />- غيبوبة (فاقد الوعي)<br />- طعم طباشيري<br />- احمرار (الهبات الساخنة)<br />- توسع الأوعية الدموية في الجلد (توسع الأوعية المحيطية).<br />- نقص بوتاسيوم الدم (انخفاض مستويات البوتاسيوم في الدم عن المعدل الطبيعي) والقلويات الأيضية (عندما<br />يصبح الدم قاعدياً جدًا) ، خاصة في المرضى الذين يعانون من قصور كلوي ، مما يسبب أعراضًا مثل:<br />- تغيرات في المزاج<br />- التعب<br />- ضيق في التنفس<br />- تصلب العضلات<br />- الوخز في العضلات<br />- تقلص العضلات<br />إذا ظهرت عليك أي من هذه الأعراض ، فعليك إبلاغ طبيبك على الفور. سيتم إيقاف الدواء وسيتم إعطاؤك<br />العلاج وفقًا للأعراض. إذا تم إضافة دواء إلى مركب الصوديوم لاكتيت الخاص بك قبل حدوث الإفراط في<br />التسريب ، فقد يؤدي هذا الدواء أيضًا إلى ظهور أعراض أخرى. يجب عليك قراءة قسم الأعراض المحتملة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية ، يمكن أن يسبب هذا المنتج آثارًا جانبية ، على الرغم من عدم حصول الجميع عليها.<br />إذا كان لديك أي من الأعراض التالية ، يجب عليك إخبار طبيبك أو ممرضتك على الفور:<br />قد تكون هذه علامات على تفاعل شديد الحساسية أو قاتل جدًا (حساسية) يسمى صدمة الحساسية<br />- الشرى التي يمكن أن تتحول إلى جزء من الجسم أو على نطاق واسع<br />- الطفح الجلدي<br />- احمرار الجلد<br />- الحكة<br />- تورم الجلد (وذمة وعائية)<br />- السعال<br />- ضيق بالشعب الهوائیة يسبب صعوبة في التنفس (تشنج قصبي)<br />- نبضات سريعة (عدم انتظام دقات القلب)<br />- نبضات بطيئة (بطء القلب)<br />- انخفاض ضغط الدم<br />- ألم في الصدر أو ألم<br />- القلق<br />- ضيق في الصدر (مما يجعل التنفس صعبًا)<br />- ضيق التنفس (ضيق التنفس)<br />- أحمرار بالوجه<br />- تهيج الحلق<br />- وخز<br />- انخفاض الشعور في الفم (نقص إفرازات الفم)<br />- تغیير الذوق<br />- الحمى<br />- غثيان<br />- صداع الراس<br />- ارتفاع مستويات البوتاسيوم في الدم عن المعدل الطبيعي (فرط بوتاسيوم الدم)<br />- انخفاض مستويات الصوديوم في الدم التي يمكن الحصول عليها أثناء العلاج في المستشفى (نقص صوديوم</p><p>الدم في المستشفيات) والاضطرابات العصبية ذات الصلة (اعتلال الدماغ الحاد بالمرض).<br />- نقص صوديوم الدم يمكن أن يؤدي إلى إصابات دماغية لا رجعة فيها والموت بسبب الوذمة الدماغية /<br />تورم انظر أيضا القسم ۲ &quot;التحذيرات والاحتياطات&quot;<br />- ردود الفعل الناجمة عن أسلوب اعطاء الدواء التي ممكن ان يظهر فيها واحد أو أكثر من الأعراض التالية:<br />- ألم موضعي أو رد فعل احمرار أو تورم في موقع التسريب<br />- تهيج والتهاب الوريد الذي تم فيه&nbsp;غرس المحلول (التهاب الوريد). هذا يمكن أن يسبب احمرار أو ألم أو<br />حرق وتورم على طول الوريد الذي يتم فيه&nbsp;غرس المحلول.<br />- طفح أو حكة من موقع التسريب.<br />الآثار الجانبية الأخرى التي لوحظت مع المنتجات المماثلة (المحاليل الأخرى التي تحتوي على لاكتات الصوديوم) تشمل:<br />- المظاهر الأخرى لفرط الحساسية / تفاعلات التسريب: الأنف المسدودة (احتقان الأنف) ، والعطس ، والتورم<br />في الحلق ، مما يجعل التنفس صعبًا (الوذمة الحنجرية تسمى أيضًا وذمة كوينك) ، تورم الجلد (وذمة وعائية)<br />- التغیرات في تركیزات المواد الكیمیائیة في الدم (اضطرابات المنحل بالكھرباء)<br />- حجم الدم أكبر في الأوعية الدموية مما ينبغي أن يكون (فرط حجم الدم)<br />- نوبة فزع<br />- ردود الفعل الأخرى بسبب أسلوب الاعطاء: العدوى في موقع الحقن ، تسريب المحلول في الأنسجة التي حول<br />الوريد .هذا يمكن أن تتلف الأنسجة ويسبب تندب في موقع التسريب.<br />- إذا تمت إضافة دواء إلى محلول التسريب ، فقد يتسبب الدواء المضاف أيضًا في حدوث آثار جانبية. تعتمد<br />هذه الآثار الجانبية على الدواء الذي تمت إضافته.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />الحفاظ على خذا الدواء بعيدا عن مرأى ومدى وصول الأطفال. يخزن في درجة حرارة لاتتعدى ۳۰ درجة<br />EXP: MM / مئوية. لا يجب إعطاء مركب الصوديوم لاكتيت لك بعد تاريخ انتهاء الصلاحية المذكور في الكيس بعد<br />يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر. يجب عدم إعطاؤك مركب الصودیوم .<br />لاكتيت إذا كانت هناك جسيمات تطفو في المحلول أو إذا تعرضت العبوة للتلف بأي طريقة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />ما يحتوي على مركب لاكتات تسريب يحتوي على:<br />المواد الفعالة ھي:<br />&bull; كلوريد الصوديوم<br />&bull; كلوريد البوتاسيوم<br />&bull; ثنائي كلوريد الكالسيوم<br />&bull; اكتات الصوديوم<br />العنصر الآخر هو الماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>لايوجد</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مصنع المحاليل الطبية.<br />العنوان:المنطقة الصناعية، المرحلة الثانية.<br />طريق رقم ۲۰۸ ، شارع ۲۰۳<br />. صندوق بريد ۱۷٤۷٦ جدة ۲۱٤۸٤<br />المنطقة الغربية<br />المملكة العربية السعودية<br />+۹٦٦-۱۲- الهاتف: ٦۳٦۱۳۸۳<br />+۹٦٦-۱۲- الفاكس: ٦۳۷۹٤٦۰<br />http://www.psiltd.com: الموقع الالكتروني</p><p>&nbsp;</p><p><strong>للإبلاغ عن أي أعراض جانبیة:</strong><br />&nbsp;</p><p>بالمملكة العربية السعودية<br />المركز الوطني للتيقظ والسلامة الدوائية<br />+ فاكس: ۹٦٦۱۱۲۰٥۷٦٦۲<br />هاتف مجاني: ۸۰۰۲٤۹۰۰۰۰<br />۰۰۹٦٦-۱۱- تلفون: ۲۰۳۸۲۲۲<br />۲۳٤۰ ،۲۳۳٤ ،۲۳٥٤ ،۲۳۱۷ ،۲۳٥٦ ، تحويلة: ۲۳٥۳<br />npc.drug@sfda.gov.sa : البريد الألكتروني<br />www.sfda.gov.sa/npc : الموقع الألكتروني<br />دول الخلیج الأخرى:<br />الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Compound Sodium Lactate Solution for Infusion BP
(Synonyms: - Ringer Lactate Solution for Infusion)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One liter contains:
Sodium Lactate………………………….3.20 g
Sodium Chloride………………………..6.00 g
Potassium Chloride……………………0.40 g
Calcium Chloride 2H2O……………… 0.27 g
Water for injections……………… 1000 ml
For the full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Compound Sodium Lactate solution is used in the following indications:<br />- Restoration of extracellular fluid and electrolytes balances or replacement of<br />extracellular fluid loss where isotonic concentrations of electrolytes are sufficient<br />- Short term volume replacement (alone or in association with colloid) in case of<br />hypovolaemia or hypotension.<br />- Regulation or maintenance of metabolic acidosis balance and/or treatment of mild<br />to moderate metabolic acidosis (except lactic acidosis)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults, the Elderly and Children:<br />Fluid balance, serum electrolytes and acid-base balance should be monitored<br />before and during administration, with particular attention to serum sodium in<br />patients with increased non-osmotic vasopressin release (syndrome of<br />inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated<br />with vasopressin agonist drugs, due to the risk of hospital acquired hyponatraemia<br />(see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly<br />important for hypotonic fluids.</p><p>Compound Sodium Lactate solution has a tonicity of 278 mOsm/l (approx.)<br />The infusion rate and volume depend on the age, weight, clinical condition (e.g.<br />burns, surgery, head-injury, infections), and concomitant therapy should be<br />determined by the consulting physician experienced in intravenous fluid therapy<br />(see sections 4.4. and 4.8).</p><p>Recommended dosage:<br />The amount of Compound Sodium Lactate solution needed to restore normal blood<br />volume is 3 to 5 times the volume of lost blood.<br />Dosage<br />The recommended flow rate 2.5 ml/kg BW/h.i.e<br />60 Drops/minute or 180 ml/h /70kg BW</p><p>Use in paediatric patients<br />The safety and efficacy of Compound Sodium Lactate solution in children has not<br />been established by adequate and well-controlled trials; however, the use of<br />electrolyte solutions in the paediatric population is referenced in the medical<br />literature. Lactate-containing solutions should be administered with particular<br />caution to neonates and infants less than 6 months of age.</p><p>Use in geriatric patients<br />When selecting the type of infusion solution and the volume/rate of infusion for a<br />geriatric patient, consider that geriatric patients are generally more likely to have<br />cardiac, renal, hepatic, and other diseases or concomitant drug therapy.</p><p>Method of administration:<br />The solution is for intravenous administration through a sterile and non-pyrogenic<br />administration set using aseptic technique. The equipment should be primed with<br />the solution in order to prevent air entering the system.<br />The solution should be inspected visually for particulate matter and discoloration<br />prior to administration. Do not administer unless the solution is clear, free from<br />visible particles and the seal is intact. Do not remove unit from overwrap until<br />ready for use. The inner bag maintains the sterility of the solution. Administer<br />immediately following the insertion of infusion set.<br />Do not connect flexible plastic containers in series in order to avoid air embolism<br />due to possible residual air contained in the primary container. Pressurizing<br />intravenous solutions contained in flexible plastic containers to increase flow rates<br />can result in air embolism if the residual air in the container is<br />not fully evacuated prior to administration. Use of a vented intravenous<br />administration set with the vent in the open position could result in air embolism.</p><p>Vented intravenous administration sets with the vent in the open position should<br />not be used with flexible plastic containers.<br />Additives may be introduced before infusion or during infusion through the<br />injection site. When making additions to Compound Sodium Lactate solution,<br />aseptic technique must be used. Mix the solution thoroughly when additives have<br />been introduced. Do not store solutions containing additives.<br />For information on incompatibilities and preparation of the product with additives,<br />please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                As for other calcium-containing infusion solutions, concomitant administration of
ceftriaxone and Compound Sodium Lactate solution is contraindicated in newborns
(≤28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxonecalcium
salt precipitation in the neonate's bloodstream). For patients over 28 days
of age please see section 4.4.
Compound Sodium Lactate solution is also contraindicated in patients with
• A known hypersensitivity to sodium lactate.
• Extracellular hyperhydration or hypervolaemia
• Severe renal insufficiency (with oliguria/anuria)
• Uncompensated cardiac failure
• Hyperkalaemia
• Hypercalcaemia
• Metabolic alkalosis
• Ascitic cirrhosis
• Severe metabolic acidosis
• Conditions associated with increased lactate levels (hyperlactataemia) including
lactic acidosis, or impaired lactate utilization, such as severe hepatic insufficiency
• Concomitant digitalis therapy (see section 4.5 Interactions with other medicinal
products and other forms of interaction)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypersensitivity reactions</strong><br />The infusion must be stopped immediately if any signs or symptoms of a suspected<br />hypersensitivity reaction develop. Appropriate therapeutic countermeasures must<br />be instituted as clinically indicated.<br />Incompatibilities<br />Ceftriaxone</p><p>In patients older than 28 days (including adults), ceftriaxone must not be<br />administered simultaneously with intravenous calcium-containing solutions,<br />including Compound Sodium Lactate solution, through the same infusion line. If<br />the same infusion line is used for sequential administration, the line must be<br />thoroughly flushed between infusions with a compatible fluid. For patients under<br />28 days please see section 4.3.</p><p><strong>Electrolyte balance</strong><br />Hypernatraemia<br />Compound Sodium Lactate solution should only be administered to patients with<br />hypernatraemia after careful consideration of the underlying cause and alternative<br />intravenous fluids. Monitoring of plasma sodium and volume status during<br />treatment is recommended.<br />Compound Sodium Lactate solution should be administered with particular caution<br />in patients with conditions predisposing to hypernatraemia (such as adrenocortical<br />insufficiency, diabetes insipidus or extensive tissue injury) and in patients with<br />cardiac disease.</p><p>Hyperchloraemia<br />Compound Sodium Lactate solution should only be administered to patients with<br />hyperchloraemia after careful consideration of the underlying cause and alternative<br />intravenous fluids. Monitoring of plasma chloride and acid-base balance during<br />treatment is recommended.<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with conditions predisposing to hyperchloraemia (such as renal failure<br />and renal tubular acidosis, diabetes insipidus), and patients with urinary diversion<br />or patients taking certain diuretics (carbonic anhydrase inhibitors eg<br />acetazolamide) or steroids (androgens, estrogens corticosteroids) and in patients<br />with severe dehydration.</p><p>Use in patients with potassium deficiency<br />Although Compound Sodium Lactate solution has a potassium concentration<br />similar to the concentration in plasma, it is insufficient to produce a useful effect in<br />case of severe potassium insufficiency and therefore it should not be used for this<br />purpose.</p><p>Use in patients at risk for hyperkalaemia<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with conditions predisposing to hyperkalaemia (such as severe renal<br />impairment or adrenocortical insufficiency, acute dehydration, or extensive tissue</p><p>injury or burns) and in patients with cardiac disease. The plasma potassium level of<br />the patient must be particularly closely monitored in patients at risk of<br />hyperkalaemia.<br />Use in patients at risk for hypercalcaemia<br />Calcium chloride is irritant, therefore care should be taken to prevent extravasation<br />during intravenous injection and intramuscular injection must be avoided.<br />Solutions containing calcium salts should be used with caution in patients with<br />conditions predisposing to hypercalcaemia, such as patients with renal impairment<br />and granulomatous diseases associated with increased calcitriol synthesis such as<br />sarcoidosis, calcium renal calculi or a history of such calculi.</p><p><strong>Fluid balance/renal function</strong><br />Use in patients with renal impairment<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients with renal impairment. In such patients administration of Compound<br />Sodium Lactate solution may result in sodium and/or potassium retention.<br />Risk of Fluid and/or Solute Overload and Electrolyte Disturbances<br />Depending on the volume and rate of infusion, intravenous administration of<br />Compound Sodium Lactate solution can cause<br />&bull; fluid and/or solute overload resulting in overhydration and, for example,<br />congested states, including pulmonary congestion and oedema.<br />&bull; clinically relevant electrolyte disturbances and acid-base imbalance.<br />Clinical evaluation and periodic laboratory determinations may be necessary to<br />monitor changes in fluid balance, electrolyte concentrations and acid-base balance<br />during prolonged parenteral therapy or whenever the condition of the patient or the<br />rate of administration warrants such evaluation.</p><p>High volume infusion must be used under specific monitoring in patients with<br />cardiac or pulmonary failure and in patients with non-osmotic vasopressin release<br />(including SIADH), due to the risk of hospital-acquired hyponatraemia (see<br />below).<br />Hyponatraemia<br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, postoperative<br />stress, infections, burns, and CNS diseases), patients with heart-, liverand<br />kidney diseases and patients exposed to vasopressin agonists (see section 4.5)<br />are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.<br />Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral<br />oedema) characterized by headache, nausea, seizures, lethargy and vomiting.</p><p>Patients with cerebral oedema are at particular risk of severe, irreversible and lifethreatening<br />brain injury.<br />Children, women in the fertile age and patients with reduced cerebral compliance<br />(e.g. meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at<br />particular risk of the severe and life-threatening brain swelling caused by acute<br />hyponatraemia.<br />Use in patients with hypervolaemia, overhydration or conditions causing sodium<br />retention and oedema<br />Compound Sodium Lactate solution should be administered with particular caution<br />to hypervolaemic or overhydrated patients.<br />Due to the sodium chloride content Compound Sodium Lactate solution should be<br />administered with particular caution to patients with conditions that may cause<br />sodium retention, fluid overload and oedema, such as patients with primary<br />hyperaldosteronism, secondary hyperaldosteronism (associated with, e.g.,<br />hypertension, congestive heart failure, renal artery stenosis, or nephrosclerosis), or<br />preeclampsia. (see also Section 4.5)</p><p><strong>Acid-base balance</strong><br />Use in patients at risk for alkalosis<br />Compound Sodium Lactate solution should be administered with particular caution<br />to patients at risk for alkalosis. Because lactate is metabolized to bicarbonate,<br />administration may result in, or worsen, metabolic alkalosis. Seizure may be<br />precipitated by the alkalosis induced by lactate but this is uncommon.</p><p><strong>Other warnings</strong><br />Administration of citrate anticoagulated/preserved blood<br />Due to the risk of coagulation precipitated by its calcium content, Compound<br />Sodium Lactate solution must not be added to or administered simultaneously<br />through the same tubing with citrate anticoagulated/preserved blood.<br />Use in patients with type 2 diabetes<br />Lactate is a substrate for gluconeogenesis. Therefore, glucose levels should be<br />carefully monitored in patients receiving Compound Sodium Lactate.<br />Administration<br />Adding other medication or using an incorrect administration technique might<br />cause the appearance of fever reactions due to the possible introduction of<br />pyrogens. In such case the infusion must be stopped immediately.<br />For information on incompatibilities and preparation of the product with additives,</p><p>please see sections 6.2 and 6.6.<br />During long term parenteral treatment, a convenient nutritive supply must be given<br />to the patient.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone: See sections 4.3 and 4.4 for more information<br />Drugs leading to an increased vasopressin effect<br />The below listed drugs increase the vasopressin effect, leading to reduced renal<br />electrolyte free water excretion and may increase the risk of hospital acquired<br />hyponatraemia following inappropriately balanced treatment with i.v. fluids (see<br />sections 4.2, 4.4 and 4.8).<br />&bull; Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate,<br />carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4-<br />methylenedioxy-N-methamphetamine, ifosfamide, antipsychotics, and narcotics.<br />&bull; Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, and<br />cyclophosphamide<br />&bull; Vasopressin analogues include: Desmopressin, oxytocin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include</p><p>diuretics in general and antiepileptics such as oxcarbazepine.<br />Interaction related to the presence of sodium:<br />Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with drugs that may increase the risk of sodium and fluid retention<br />(with oedema and hypertension), such as corticosteroids.<br />Interaction related to the presence of potassium:<br />Because of its potassium content, Compound Sodium Lactate solution should be<br />administered with caution in patients treated with agents or products that can cause<br />hyperkalaemia or increase the risk of hyperkalaemia, such as<br />- Potassium-sparing diuretics (amiloride, spironolactone, triamterene, alone or in<br />association).<br />- Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor<br />antagonists<br />- Tacrolimus, cyclosporine</p><p>Administration of potassium in patients treated with such medications can produce<br />severe and potentially fatal hyperkalaemia, particularly in patients with severe<br />renal insufficiency.<br />Interaction related to the presence of calcium:<br />Administration of calcium may increase the effects of digitalis and lead to serious<br />or fatal cardiac arrhythmia. Therefore, larger volumes or a faster infusion rates<br />should be used with caution in patients treated with digitalis glycosides.</p><p>- Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with thiazide diuretics or vitamin D, as these can increase the risk<br />of hypercalcaemia.<br />- Bisphosphonates, fluoride, some fluoroquinolones and tetracyclines which are<br />less absorbed (lower availability) when administered with calcium.<br />Interaction related to the presence of lactate (which is metabolized into<br />bicarbonate):<br />Caution is advised when administering Compound Sodium Lactate solution to<br />patients treated with drugs for which renal elimination is pH dependent. Due to the<br />alkalinizing action of lactate (formation of bicarbonate), Compound Sodium<br />Lactate solution may interfere with the elimination of such drugs.<br />- Renal clearance of acidic drugs such as salicylates, barbiturates, and lithium may<br />be increased because of the alkalinisation of urine by the bicarbonate resulting<br />from lactate metabolism.</p><p>- Renal clearance of alkaline drugs, such as sympathomimetics (e.g. ephedrine,<br />pseudoephedrine) and stimulants (e.g. dexamphetamine sulfate, phenfluramine<br />hydrochloride) may be decreased</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Compound Sodium Lactate solution can be used safely during pregnancy and<br />lactation as long as the electrolyte- and fluid balance is controlled.<br />It is reminded that calcium crosses the placenta and is distributed into breast milk.<br />Compound Sodium Lactate solution should be administrated with special caution<br />for pregnant women during labour particularly as to serum-sodium if administered<br />in combination with oxytocin (see section 4.4, 4.5 and 4.8).<br />When a medication is added, the nature of the drug and its use during pregnancy<br />and lactation have to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information of the effects of Compound Sodium Lactate solution on<br />the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions (listed by MedDRA System Organ Class) have<br />been reported spontaneously during the post-market experience.</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:243px">Immune System Disorders</td><td style="width:255px">Hypersensitivity/Infusion reactions including<br />Anaphylactic/Anaphylactoid reaction, possibly<br />manifested by one or more of the following</td></tr><tr><td style="width:243px">&nbsp;</td><td style="width:255px">symptoms: Angioedema, Chest pain, Chest<br />discomfort, Decreased heart rate, Tachycardia,<br />Blood pressure decreased, Respiratory distress,<br />Bronchospasm, Dyspnea, Cough, Urticaria,<br />Rash, Pruritus, Erythema, Flushing, Throat<br />irritation, Paresthesias, Hypoesthesia oral,<br />Dysgeusia, Nausea, Anxiety, Pyrexia,<br />Headache</td></tr><tr><td style="width:243px">Metabolism and Nutrition Disorders</td><td style="width:255px">Hyperkalaemia<br />Hospital acquired hyponatraemia*</td></tr><tr><td style="width:243px">Nervous system disorders</td><td style="width:255px">Acute hyponatraemic encephalopathy*</td></tr><tr><td style="width:243px">General Disorders and Administration Site<br />Conditions</td><td style="width:255px">Infusion Site Reactions manifested by one or<br />more of the following symptoms: Phlebitis,<br />Infusion site inflammation, Infusion site<br />swelling, Infusion site rash, Infusion site<br />pruritus, Infusion site erythema, Infusion site<br />pain, Infusion site burning</td></tr></tbody></table><p>*Hospital acquired hyponatraemia may cause irreversible brain injury and death,<br />due to development of acute hyponatraemic encephalopathy, frequency unknown<br />(see sections 4.2. 4.4, 4.5).<br />The following adverse reactions have been reported spontaneously during the use<br />of other sodium-lactate containing solutions:<br />&bull; Hypersensitivity: Laryngeal oedema (Quincke&#39;s oedema), skin swelling, Nasal<br />congestion, Sneezing<br />&bull; Electrolyte disturbances<br />&bull; Hypervolaemia<br />&bull; Panic Attack<br />&bull; Other infusion site reactions: Infection at the site of injection, Extravasation,<br />Infusion site anesthesia (numbness)</p><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product<br />is important. It allows continued monitoring of the benefit/risk balance of the<br />medicinal product.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume or too high a rate of administration of Compound Sodium<br />Lactate solution may lead to fluid and sodium overload with a risk of oedema<br />(peripheral and/or pulmonary), particularly when renal sodium excretion is<br />impaired. In this case extra renal dialysis may be necessary.<br />Excessive administration of potassium may lead to the development of<br />hyperkalaemia, especially in patients with renal impairment. Symptoms include<br />paresthesia of the extremities, muscle weakness, paralysis, cardiac arrhythmias,<br />heart block, cardiac arrest, and mental confusion</p><p>Excessive administration of calcium salts may lead to hypercalcaemia. Symptoms<br />of hypercalcaemia may include anorexia, nausea, vomiting, constipation,<br />abdominal pain, muscle weakness, mental disturbances, polydipsia, polyuria,<br />nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma.<br />Too rapid intravenous injection of calcium salts may also lead to many of the<br />symptoms of hypercalcaemia as well as to chalky taste, hot flushes, and peripheral<br />vasodilatation. Mild asymptomatic hypercalcaemia will usually resolve on<br />stopping administration of calcium and other contributory drugs such as vitamin D.<br />If hypercalcaemia is severe, urgent treatment (such as loop diuretics,<br />haemodialysis, calcitonin, bisphosphonates, trisodium edetate) is required.</p><p>Excessive administration of lactate may lead to metabolic alkalosis. Metabolic<br />alkalosis may be accompanied by hypokalaemia, Symptoms may include mood<br />changes, tiredness, shortness of breath, muscle weakness and irregular heartbeat.<br />Muscle hypertonicity, twitching, and tetany may develop especially in<br />hypocalcaemic patients. Treatment of metabolic alkalosis due to bicarbonate<br />overdose consists mainly of appropriate correction of fluid and electrolyte balance.<br />Replacement of calcium, chloride, and potassium may be of particular importance.</p><p>When overdose is related to medications added to the solution infused, the signs<br />and symptoms of over infusion will be related to the nature of the additive being<br />used. In the event of accidental over infusion, treatment should be discontinued<br />and the patient should be observed for the appropriate signs and symptoms related<br />to the drug administered. The relevant symptomatic and supportive measures<br />should be provided as necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group (ATC code): B05BB01 &ldquo;Electrolytes&rdquo;</p><p>Compound Sodium Lactate solution is an isotonic solution of electrolytes. The<br />constituents of Compound Sodium Lactate Solution and their concentrations are<br />designed to match those of plasma.<br />The pharmacological properties of the Compound Sodium Lactate solution are<br />those of its components (sodium, potassium, calcium, chloride and lactate). The<br />main effect of Compound Sodium Lactate Solution is the expansion of the<br />extracellular compartment including both the interstitial fluid and the intravascular<br />fluid.<br />The lactate is metabolised into bicarbonate, mainly in the liver, and produces an<br />alkalinising effect on the plasma<br />In healthy volunteers receiving Compound Sodium Lactate Solution, central<br />venous pressure changes were associated with a secretion of atrial natriuretic<br />peptide<br />In healthy volunteers, Compound Sodium Lactate Solution decreased serum<br />osmolality, increased blood pH, and the time until first urination was shorter than&nbsp;that with normal saline.</p><p>There is no significant change in glucagon, norepinephrine, epinephrine, blood<br />glucose and insulin levels in aortic surgery patients receiving Compound Sodium<br />Lactate Solution.<br />When medication is added to Compound Sodium Lactate Solution, the overall<br />pharmacodynamics of the solution will depend on the nature of the drug used.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of the Compound Sodium Lactate solution are<br />those of the ions its composition includes (sodium, potassium, calcium and<br />chloride).<br />Infusion of Compound Sodium Lactate Solution in normal hemodynamically stable<br />adults does not increase circulating lactate concentrations.<br />The pharmacokinetics of D-lactate and L-lactate are similar. The lactate in<br />Compound Sodium Lactate solution is metabolized by both oxidation and<br />gluconeogenesis, predominantly in the liver, and bicarbonate is generated by both<br />processes over 1-2 h.<br />When medication is added to Compound Sodium Lactate Solution, the overall<br />pharmacokinetics of the solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of Compound Sodium Lactate Solution in animals are not<br />relevant since its constituents are physiological components in animal and human<br />plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone must not be mixed with calcium-containing solutions including<br />Compound Sodium Lactate solution. See also sections 4.3 and 4.4.<br />As with all parenteral solutions additives may be incompatible. Compatibility of<br />the additives with the Compound Sodium Lactate solution and Viaflo container<br />must be assessed before addition. After addition of the additive, incompatibility<br />may become visible by a possible colour change and/or the appearance of<br />precipitates, insoluble complexes or crystals.<br />The Instructions for Use of the medication to be added and other relevant literature<br />must be consulted.<br />Before adding a substance or medication, verify that it is soluble and/or stable in<br />water and that the pH range of Compound Sodium Lactate solution is appropriate<br />(pH 5.0 to 7.0).<br />When making additions to Compound Sodium Lacate solution, aseptic technique<br />must be used. Mix the solution thoroughly when additives have been introduced.<br />Do not store solutions containing additives.</p><p>As a guidance the following medications are incompatible with the Compound<br />Sodium Lactate solution (non-exhaustive listing):<br />Medications incompatible with Compound Sodium Lactate Solution<br />Aminocaproic acid<br />Amphotericin B<br />Metaraminol tartrate<br />Cefamandole<br />Ceftriaxone<br />Cortisone acetate<br />Diethylstilbestrol<br />Etamivan<br />Ethyl alcohol<br />Phosphate and carbonate solutions<br />Oxytetracycline</p><p>Thiopental sodium<br />Versenate disodium<br />Medications with partial incompatibility with Compound Sodium Lactate Solution:<br />Tetracycline stable for 12 hours<br />Ampicillin sodium<br />concentration of 2%-3% stable for 4 hours<br />concentration &gt;3% must be given within 1 hour</p><p>Minocycline stable for 12 hours<br />Doxycycline stable for 6 hours<br />Additives known or determined to be incompatible should not be used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 months for plastic bottle.
24 months for NPVC bag.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C<br />Do not store above 25&deg;C for sizes: 250 ml NPVC bag.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The product is a clear, colorless solution in over wrapped Non-PVC Bag with two<br />SFC ports and Polyethylene plastic bottle.<br />The solutions are supplied in 250ml, 500 ml, 1000 ml and 3000 ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After opening the container, the contents should be used immediately and should<br />not be stored for a subsequent infusion.<br />Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharmaceutical Solutions Industry Ltd.
Industrial Estate, Phase-2,
Road No. 208, Str. - 203
P O Box 17476
Jeddah 21484
Western Province
Saudi Arabia
Phone: +966-12-6361383
FAX: +966-12-6379460
Website: http://www.psiltd.com

To report any side effect(s):

For Saudi Arabia:

The National Pharmacovigilance and Drug Safety Centre (NPC)

* Fax: +966-11-205-7662

* Reporting hotline: 19999.

* E-mail: npc.drug@sfda.gov.sa

* Website: www.sfda.gov.sa/npc

Other GCC States:
Please contact the relevant competent authority
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06/2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>